Okazaki fragments sequencing (OK-seq)

OK-seq enables researchers to map the genome-wide locations of proteins involved in DNA replication and replication fork directionality. By unraveling the spatial organization of replication machinery and Okazaki fragments, OK-seq offers insights into the coordination and regulation of DNA synthesis during genome replication. This approach provides information for understanding genome stability and cellular proliferation.

Global run-on sequencing (GRO-seq)

GRO-seq allows researchers to map the locations of actively transcribing RNA polymerases and nascent RNA molecules to study the regulation and coordination of gene expression. This technique facilitates the identification of transcriptional enhancers, promoters, and regulatory elements, shedding light on the orchestration of cellular processes and the molecular basis of disease.

CITE-seq

CITE-seq combines single-cell RNA sequencing with protein detection to analyze cell populations in detail. Our platform facilitates comprehensive characterization of cell types, states, and interactions, enabling to profile immune cell responses,to identify rare cell populations, or to unravel disease mechanisms

Mouse Model – B-cell Lymphoma

Gain access to our engineered mouse models, including CD19-Cre transgenic strain (allowing conditional engineering in B cells), BCL2tracer strain (mimicking sporadic t(14;18) translocation), AID-Cre-ERT2 KI/KO strain (used to monitor memory B cell population), RosaYFP Reporter strain, MLL4 f/F strain, Cas9-GFP Cre strain, and BCL2/KDMT2D knock-out strain (either as a syngenic chimera model or xenograft), and […]

ECCITE-seq

ECCITE-seq combines CRISPR perturbations, RNA sequencing, and protein detection at the single-cell level, enabling integrated analysis of transcriptome, genome, and proteome. This technique provides deep insights into cellular states and regulatory networks, serving as a powerful tool for CRISPR screens, functional genomics, and precision medicine research.

CRISPR Screening Platform

This academic platform proposes to perform CRISPR-based screens, enabling the comprehensive interrogation of the functional consequences of a genomic modification at the whole-genome scale, revealing how genomic alterations in coding or regulatory regions lead to phenotypic changes. The coordinator of the platform is Sandrine Roulland.

Patient Derived Organoids – Follicular lymphoma

Discover our organoid model derived from FL patient primary cells (tumor and microenvironment), cultured in vitro on a peptide-based gel matrix. This system enables drug and target discovery through gene expression modulation and extensive screening of small molecules, antibodies, and CAR-T cells. Each sample is linked to clinical data and integrated into a predictive model […]

Mouse Model – DLBCL/FL

Gain access to our mouse models in FL/DLBCL, including vavP-BCL2 strain, KMT2D-flox CD19-cre strain and BTG1-KO strain (and more). These models enable to investigate novel drug targets and test for drug efficacy and toxicity

Genome Integrity Analysis: Replication and DNA Damage Detection

Our expertise include DNA combing, detection of cytosolic DNA and detection of DNA damage foci, enabling detailed study of DNA replication and genome stability. Allowing quantification of replication stress, fork resection, and DNA damage at both single-molecule and cellular levels, they help uncover mechanisms of cancer progression, inflammation, and potential therapeutic targets.

Nous contacter